Cardiovascular Bioengineering (CVBE) Symposium - 2019

项目摘要 这是一个新的应用程序，用于支持2019年增加受训人员和初级科学家参与的努力 心血管生物工程研讨会将在悉尼大学校园举行， 澳大利亚。这将是研讨会召开四周年。CVBE研讨会的独特之处在于它 心血管生物工程领域的顶尖研究人员、实习生、初级研究人员和 代表不足的少数族裔。研讨会将为受训人员、初级调查人员和少数族裔调查人员提供一个论坛 在世界顶尖科学家展示他们的工作时与他们互动。这部作品反映了生活的趋同 在基因编辑、诱导多能干细胞和心脏干细胞领域的科学和工程 心力衰竭的背景以及心血管生物工程的一般主题。这次会议有 之前与NIH NHLBI祖细胞翻译分开(但结合)举行 由阿拉巴马大学伯明翰分校(UAB)在过去3年的1、2、3、4年中由NIH PCTC联盟(NIH PCTC)主办。这个 2016年，会议成为一年一度的公开研讨会，从那时起，这次会议就被公认为 干细胞和心血管生物工程的一次独特的公开和重复的科学研讨会。这个 近两年的会议增加了翻译话题以及这次会议的“面包和黄油”， 包括基础干细胞生物工程、分子心血管研究和组织工程。这个 会议吸引了世界领先的心脏干细胞领域的科学家1、2、3、4原创 会议主题从组织工程学、髋关节细胞、心脏发育开始，最近两年 包括外体、微RNA、线粒体、心脏基因和心脏细胞治疗。出席的人 本届大会数量不断攀升，2018年，出席人数超过200人。与过去几年一样，会议将 将于2月底/3月初举行，今年将于3月1日至2日在悉尼大学举行。这个 计划议程代表了一次雄心勃勃、快节奏的会议，包括主旨演讲在内，在1.5天内举行了8次会议 讲课。年轻的心血管科学家将在每一次会议上通过特邀演讲得到强调。主办方 本次会议是张建义(Jay)博士(UAB)、James Chong(悉尼大学)、秦健(UAB)和Joel 贝瑞(Berry)。这项提议需要10,000美元，正如我们在过去几年中所做的那样，支持 将用于实习生旅费、实习生海报会议奖励、会议用品和 支持对所有会话进行录像。

Project Summary This is a new application to support efforts to increase involvement of trainees and junior scientists for the 2019 Cardiovascular Bioengineering Symposium (CVBE) to be held on the campus of The University of Sydney, Australia. This will be the 4th Anniversary of the Symposium. The uniqueness of the CVBE symposium lies in its combination of top researchers in cardiovascular bioengineering, trainees, junior investigators, and underrepresented minorities. The symposium will provide a forum for trainees, junior and minority investigators to interact with world's leading scientists as they present their work. This work reflects the convergence of life sciences and engineering in the areas of gene editing, induced pluripotent stem cells, and cardiac stem cells in the context of heart failure as well general topics in cardiovascular bioengineering. This conference has previously been held separately from (but in conjunction with) the NIH NHLBI progenitor cell translational consortium (NIH PCTC) for the past 3 years1, 2, 3, 4 by The University of Alabama at Birmingham (UAB). The meeting became an annual public symposium in 2016, and since then, this conference has been recognized as a unique public and recurring scientific symposium of stem cell and cardiovascular bioengineering. The conference in recent 2 years has added translational topics as well as the “bread and butter” of this meeting, which is basic stem cell bioengineering, molecular cardiovascular research, and tissue engineering. The conference has attracted the world's leading scientists in field of cardiac stem cells.1, 2, 3, 4 The original conference topics started with tissue engineering, hiPS cells, cardiac development, and recent two years has grown to include exosome, microRNAs, mitochondria, cardiac gene and cardiac cell therapy. The attendance of this conference has climbed and, in 2018, we had attendance of over 200. As in past years, the conference will be held in late February/early March, and this year, will be held March 1-2 at The University of Sydney. The planned agenda represents an ambitious, fast-paced meeting with 8 sessions in 1.5 days including the Keynote lecture. Young cardiovascular scientists will be highlighted through invited talks at each session. Organizers of this meeting are Drs. Jianyi (Jay) Zhang (UAB), James Chong (U of Sydney), Gangjian Qin (UAB), and Joel Berry (UAB). This proposal requests $10,000, and as we have done over the last several years, the support will be used towards the cost of trainee travel, trainee poster session awards, meeting supplies, and support for videotaping all sessions.